PubMed Health⌕ Search

PubMed · 228784

Does impaired diffusion for oxygen exist in diseased lungs?

Abstract

The historical development of ideas concerning impairment of diffusion in the lungs (alveolar-capillary block) is described. The major publications by Riley and Cournand, and others, which showed that impairment of diffusion exists in some diseased lungs were based on careful measurements of the arterial oxygen tension or saturation of patients. These papers described work carried out in the State of New York. Other workers claim to have shown that impairment of diffusion does not exist in diseased lungs: the impairment of oxygen transfer in alveolar-capillary block is said to be due to uneven ventilation-perfusion ratios. The publications which adopt this point of view are mostly based on measurements of the concentration of inert gases in the arterial blood. By chance, the workers who found that diffusion is not impaired in diseased lungs were all in the State of California. It is pointed out here that the California workers have failed to recognize that diffusion, like ventilation and perfusion, is distributed, i.e. varies greatly in different alveoli. This led them to ignore the fact that in some alveoli in diseased lungs, diffusion is so greatly impaired that some inert gases do not reach equilibrium at the end of the pulmonary capillary: the tension of inert gas in end-capillary blood is different from the tension of the same gas in alveolar gas. This invalidates the basic assumption underlying the inert gas method.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

W A Briscoe. Does impaired diffusion for oxygen exist in diseased lungs?. https://pubmed.ncbi.nlm.nih.gov/228784/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗